Literature DB >> 1430362

Immunohistochemical examination of lichen nitidus suggests that it is not a localized papular variant of lichen planus.

B R Smoller1, T C Flynn.   

Abstract

BACKGROUND: Lichen nitidus is believed, by some, to be a variant of lichen planus, and by others to be a distinct entity.
OBJECTIVE: We examined five cases of lichen nitidus with immunohistochemical reagents designed to characterize the dermal inflammatory infiltrate in an attempt to resolve the uncertainty.
METHODS: We stained formalin-fixed, paraffin-embedded tissue sections with the following antibodies: L26, A6, KP1, BerH2, OPD4, and HECA-452.
RESULTS: The inflammatory infiltrate was 90% A6+, with few L26+ cells. In contrast to lichen planus, KP1+ macrophages were seen and fewer of the lymphocytes demonstrated HECA-452. Fifty percent to 80% of lymphocytes were OPD4 positive, similar to that usually seen in lichen planus. Rare Ki-1+ cells were seen in one case.
CONCLUSION: We believe that the pattern of a mixed cellular infiltrate characterized by macrophages and a helper T cell response with few HECA-452+ cells is somewhat different from the pattern seen in lichen planus, wherein almost all of the cells are CD4+/HECA-452+ lymphocytes. This suggests a different immunologic pathogenesis.

Entities:  

Mesh:

Year:  1992        PMID: 1430362     DOI: 10.1016/0190-9622(92)70176-g

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  2 in total

1.  Three cases of lichen nitidus associated with various cutaneous diseases.

Authors:  Eun Byul Cho; Heung Yeol Kim; Eun Joo Park; In Ho Kwon; Kwang Ho Kim; Kwang Joong Kim
Journal:  Ann Dermatol       Date:  2014-07-31       Impact factor: 1.444

2.  Generalized lichen nitidus: a case report and review of the literature.

Authors:  Joanna Synakiewicz; Adriana Polańska; Monika Bowszyc-Dmochowska; Ryszard W Żaba; Zygmunt Adamski; Adam Reich; Aleksandra Dańczak-Pazdrowska
Journal:  Postepy Dermatol Alergol       Date:  2016-12-02       Impact factor: 1.837

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.